Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7OUT

HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-264

Summary for 7OUT
Entry DOI10.2210/pdb7out/pdb
Related7OT6 7OTA 7OTK 7OTN 7OTX 7OTZ
DescriptorReverse transcriptase/ribonuclease H, DNA (5'-D(P*GP*GP*TP*CP*GP*GP*CP*GP*CP*CP*CP*GP*AP*AP*CP*AP*GP*GP*GP*AP*CP*TP*G)-3'), DNA (5'-D(*CP*AP*GP*TP*CP*CP*CP*TP*GP*TP*TP*CP*GP*GP*(MRG)P*CP*GP*CP*CP*(DDG))-3'), ... (7 entities in total)
Functional Keywordsreverse transcriptase, rt inhibitor complex, acyclic nucleoside phosphonate analog, rt-dna complex, transferase
Biological sourceHuman immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1)
More
Total number of polymer chains8
Total formula weight258208.66
Authors
Martinez, S.E.,Singh, A.K.,Gu, W.,Das, K. (deposition date: 2021-06-13, release date: 2021-12-08, Last modification date: 2024-01-31)
Primary citationGu, W.,Martinez, S.,Singh, A.K.,Nguyen, H.,Rozenski, J.,Schols, D.,Herdewijn, P.,Das, K.,De Jonghe, S.
Exploring the dNTP -binding site of HIV-1 reverse transcriptase for inhibitor design.
Eur.J.Med.Chem., 225:113785-113785, 2021
Cited by
PubMed Abstract: HIV-1 reverse transcriptase (RT) plays a central role in the viral life cycle, and roughly half of the FDA-approved anti-HIV drugs are targeting RT. Nucleoside analogs (NRTIs) require cellular phosphorylation for binding to RT, and to bypass this rate-limiting path, we designed a new series of acyclic nucleoside phosphonate analogs as nucleoside triphosphate mimics, aiming at the chelation of the catalytic Mg ions via a phosphonate and/or a carboxylic acid group. Novel synthetic procedures were developed to access these nucleoside phosphonate analogs. X-ray structures in complex with HIV-1 RT/dsDNA demonstrated that their binding modes are distinct from that of our previously reported compound series. The impact of chain length, chirality and linker atom have been discussed. The detailed structural understanding of these new compounds provides opportunities for designing new class of HIV-1 RT inhibitors.
PubMed: 34425311
DOI: 10.1016/j.ejmech.2021.113785
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.2 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon